248 related articles for article (PubMed ID: 8882027)
41. Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial.
van der Laan W; Molenaar E; Ronday K; Verheijen J; Breedveld F; Greenwald R; Dijkmans B; TeKoppele J
J Rheumatol; 2001 Sep; 28(9):1967-74. PubMed ID: 11550961
[TBL] [Abstract][Full Text] [Related]
42. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W
Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899
[TBL] [Abstract][Full Text] [Related]
43. Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease.
Steens RD; Pouliot Z; Millar TW; Kryger MH; George CF
Sleep; 1993 Jun; 16(4):318-26. PubMed ID: 8341892
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
[TBL] [Abstract][Full Text] [Related]
45. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
Lee H; Kim SW; Kim JM; Shin IS; Yang SJ; Yoon JS
Hum Psychopharmacol; 2005 Mar; 20(2):97-104. PubMed ID: 15641125
[TBL] [Abstract][Full Text] [Related]
46. Decreasing pain and anxiety associated with patient-activated atrial shock: a placebo-controlled study of adjunctive sedation with oral triazolam.
Fabian TJ; Schwartzman DS; Ujhelyi MR; Corey SE; Bigos KL; Pollock BG; Kroboth PD
J Cardiovasc Electrophysiol; 2006 Apr; 17(4):391-5. PubMed ID: 16643361
[TBL] [Abstract][Full Text] [Related]
47. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
Riemann D; Voderholzer U; Cohrs S; Rodenbeck A; Hajak G; Rüther E; Wiegand MH; Laakmann G; Baghai T; Fischer W; Hoffmann M; Hohagen F; Mayer G; Berger M
Pharmacopsychiatry; 2002 Sep; 35(5):165-74. PubMed ID: 12237787
[TBL] [Abstract][Full Text] [Related]
48. Dose-response effects of zaleplon as compared with triazolam (0.25 mg) and placebo in chronic primary insomnia.
Drake CL; Roehrs TA; Mangano RM; Roth T
Hum Psychopharmacol; 2000 Dec; 15(8):595-604. PubMed ID: 12404612
[TBL] [Abstract][Full Text] [Related]
49. The use of triazolam in older patients with periodic leg movements, fragmented sleep, and daytime sleepiness.
Bonnet MH; Arand DL
J Gerontol; 1990 Jul; 45(4):M139-44. PubMed ID: 2195102
[TBL] [Abstract][Full Text] [Related]
50. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
Farber RH; Burke PJ
Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978
[TBL] [Abstract][Full Text] [Related]
51. Does valerian improve sleepiness and symptom severity in people with restless legs syndrome?
Cuellar NG; Ratcliffe SJ
Altern Ther Health Med; 2009; 15(2):22-8. PubMed ID: 19284179
[TBL] [Abstract][Full Text] [Related]
52. Night medication in rheumatoid arthritis.
Bayley TR; Haslock I
J R Coll Gen Pract; 1976 Aug; 26(169):591-4. PubMed ID: 787518
[TBL] [Abstract][Full Text] [Related]
53. Acutely shifting the sleep-wake cycle: nighttime sleepiness after diurnal administration of temazepam or placebo.
Porcù S; Bellatreccia A; Ferrara M; Casagrande M
Aviat Space Environ Med; 1997 Aug; 68(8):688-94. PubMed ID: 9262809
[TBL] [Abstract][Full Text] [Related]
54. Daytime sleepiness, performance, mood, nocturnal sleep: the effect of benzodiazepine and caffeine on their relationship.
Johnson LC; Spinweber CL; Gomez SA; Matteson LT
Sleep; 1990 Apr; 13(2):121-35. PubMed ID: 2184488
[TBL] [Abstract][Full Text] [Related]
55. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.
Jacobs GD; Pace-Schott EF; Stickgold R; Otto MW
Arch Intern Med; 2004 Sep; 164(17):1888-96. PubMed ID: 15451764
[TBL] [Abstract][Full Text] [Related]
56. Nocturnal sleep, daytime sleepiness and fatigue in fibromyalgia patients compared to rheumatoid arthritis patients and healthy controls: a preliminary study.
Roehrs T; Diederichs C; Gillis M; Burger AJ; Stout RA; Lumley MA; Roth T
Sleep Med; 2013 Jan; 14(1):109-15. PubMed ID: 23149217
[TBL] [Abstract][Full Text] [Related]
57. Daytime carryover of triazolam and flurazepam in elderly insomniacs.
Carskadon MA; Seidel WF; Greenblatt DJ; Dement WC
Sleep; 1982; 5(4):361-71. PubMed ID: 6131526
[TBL] [Abstract][Full Text] [Related]
58. Quazepam versus triazolam in patients with sleep disorders: a double-blind study.
Mauri MC; Gianetti S; Pugnetti L; Altamura AC
Int J Clin Pharmacol Res; 1993; 13(3):173-7. PubMed ID: 7901174
[TBL] [Abstract][Full Text] [Related]
59. Residual effects of repeated administration of triazolam and nitrazepam in healthy volunteers.
Muraoka M; Tada K; Nogami Y; Ishikawa K; Nagoya T
Neuropsychobiology; 1992; 25(3):134-9. PubMed ID: 1407479
[TBL] [Abstract][Full Text] [Related]
60. Effects of tandospirone, a 5-HT1A receptor-related anxiolytic, on daytime sleepiness and psychomotor functions: a comparative double-blind study with diazepam.
Suzuki M; Uchiumi M; Murasaki M
Yakubutsu Seishin Kodo; 1993 Aug; 13(4):213-24. PubMed ID: 7901952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
